
China’s central bank will “deepen” its antitrust investigations into the mobile payment sector, which has been dominated by a few private financial technology firms, despite “interim progress” made in the last year, its deputy governor said on Friday, September 24.
Beijing has enhanced the regulation surrounding Big Tech companies and has indicated a continued clampdown amid the country’s prolonged de-risking strategy.
“The antitrust actions in the payment sector need to deepen,” Fan Yifei told China Payment and Clearing Forum in Beijing. “The central bank will persistently urge platform companies to rectify their payment businesses.”
Mobile payments are one of the most visible parts in China’s fast-growing digital economy, which rose by 9.6 per cent to US$5.4 trillion last year to become the world’s second largest only behind the United States.
Central bank data showed that non-banking payment agencies – which are headlined by Tencent’s WeChat Pay and Ant Group’s Alipay – handled 294.6 trillion yuan (US$45.6 trillion) across 827.3 billion transactions last year, up by 17.9% and 14.9%, respectively, from a year earlier.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas